Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Nutrients|November 13, 2025
The Mediating Role of Bioactive Molecules in Gut Microbiota-Bone Metabolism CrosstalkXinping Liang, Luoyang WangMicroorganisms|January 30, 2020
Biostimulating Gut Microbiome with Bilberry Anthocyanin Combo to Enhance Anti-PD-L1 Efficiency against Murine Colon CancerXuerun Liu, Luoyang Wang, Nan Jing, et al.Frontiers in Immunology|July 12, 2023
Enhancing therapeutic effects of murine cancer vaccine by reshaping gut microbiota with <i>Lactobacillus rhamnosus</i> GG and jujube powderNan Jing, Luoyang Wang, Huiren Zhuang, et al.Cancers|August 27, 2021
Ultrafine Jujube Powder Enhances the Infiltration of Immune Cells during Anti-PD-L1 Treatment against Murine Colon AdenocarcinomaNan Jing, Luoyang Wang, Huiren Zhuang, et al.Nutrients|August 27, 2021
Jujube Powder Enhances Cyclophosphamide Efficiency against Murine Colon Cancer by Enriching CD8<sup>+</sup> T Cells While Inhibiting EosinophiliaHuiren Zhuang, Nan Jing, Luoyang Wang, et al.Frontiers in Immunology|May 28, 2026
Unlocking the potential: current landscape and future directions of immunotherapy in gastric cancerYingfei Zhou, Luling Wei, Luoyang Wang, et al.BMC Complementary Medicine and Therapies|October 16, 2020
Glycosylation of anthocyanins enhances the apoptosis of colon cancer cells by handicapping energy metabolismNan Jing, Jiaxing Song, Zheng Liu, et al.Frontiers in Immunology|August 15, 2022
Promoting intestinal IgA production in mice by oral administration with anthocyaninsXuerun Liu, Luoyang Wang, Huiren Zhuang, et al.International Journal of Cancer|February 24, 2026
The CXCL12-CXCR4/CXCR7 axis as a therapeutic target in liver cancer: Enhancing immune evasion and the future of combination therapiesMeiying Song, Xueteng Wang, Jie Liang, et al.Journal of Immunology Research|July 29, 2022
Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon CancerNan Jing, Luoyang Wang, Huiren Zhuang, et al.Pageof 5